Evaluation the Efficiency of Intravenous Dexmedetomidine Under Nasal Humidification Rapid Ventilation Device Without Intubation in Laryngoscope Microsurgery

Sponsor
Kaohsiung Veterans General Hospital. (Other)
Overall Status
Recruiting
CT.gov ID
NCT05581485
Collaborator
(none)
90
1
3
13
6.9

Study Details

Study Description

Brief Summary

Method This single-center randomized-controlled trial is conducted to compare the efficiency of LMS with intubated general anesthesia(ITGA) and LMS with nonintubated anesthesia. The study also performed a comparative evaluation of the safety and feasibility of LMS with nonintubated general anesthesia under two different ventilation strategies. The investigators plan to enroll patients aged between 20 and 80 years who required LMS.

This study has divided into three groups: the first group was LMS patients receiving general intubation general anesthesia(ITGA group). The second group consisted of LMS patients who received non-intubated general anesthesia and performed SLNB(SLNB group). The third group was LMS patients who received non-intubated general anesthesia and were given Dexmedetomidine(Dex group)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Non-intubated Laryngomicrosurgery
N/A

Detailed Description

Background Laryngeal microsurgery(LMS) is among the most common operations in otolaryngology and typically requires general anesthesia administered through endotracheal tube intubation. Endotracheal tube intubation provides stable gas exchange, protects the airways by preventing secretions from falling into the lower respiratory tract, and enables the monitoring of parameters such as tidal volume and end-tidal carbon dioxide(CO2).

Nonintubated anesthesia applied in combination with transnasal humidified rapid-insufflation ventilatory exchange or high-flow nasal oxygen(HFNO) is another option for LMS. LMS with nonintubated anesthesia can avoid the complications caused by endotracheal tube intubation such as oral tissue trauma, tracheal trauma, and dental injury. Furthermore, LMS with nonintubated anesthesia can provide a clearer surgical field of vision that allows the vocal cords to be comprehensively inspected and treated.

Current practice in LMS with nonintubated anesthesia is to perform superior laryngeal nerve block(SLNB) to help avoid bucking during the procedure. However, performing SLNB is an invasion procedure can lead to some complication such as bleeding, nerve injury or vessel injury.

Therefore, the investigators investigated the administration of dexmedetomidine with intravenous general anesthesia, it is can help the patient maintain spontaneous breathing, and provide higher surgical safety during LMS with nonintubated anesthesia.

Method This single-center randomized-controlled trial is conducted to compare the efficiency of LMS with intubated general anesthesia(ITGA) and LMS with nonintubated anesthesia. The study also performed a comparative evaluation of the safety and feasibility of LMS with nonintubated general anesthesia under two different ventilation strategies. The investigators plan to enroll patients aged between 20 and 80 years who required LMS.

This study has divided into three groups: the first group was LMS patients receiving general intubation general anesthesia(ITGA group). The second group consisted of LMS patients who received non-intubated general anesthesia and performed SLNB(SLNB group). The third group was LMS patients who received non-intubated general anesthesia and were given Dexmedetomidine(Dex group) The exclusion criteria were as follows: presence of severe airway obstruction, severe airway disease, American Society of anesthesiologists(ASA) physical state > III, pregnancy, or body mass index(BMI)≥40kg/m2.

This project is expected to improve the success rate of microlaryngoscopy in non-intubated anesthetized patients, in addition to the excellent surgical field and complete vocal cord examination, the use of dexmedetomidine instead of SLNB can provide good safety for non-intubated LMS .

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation the Efficiency of Intravenous Dexmedetomidine Under Nasal Humidification Rapid Ventilation Device Without Intubation in Laryngoscope Microsurgery
Actual Study Start Date :
Nov 29, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Intubated general anesthesia LMS

The patients received a LMS with intubated general anesthesia.

Experimental: Non-intubated LMS with spontaneous breathing

The patients received a non-intubated LMS optiflow(HFNO) device and maintained spontaneous breathing.

Procedure: Non-intubated Laryngomicrosurgery
Non-intubated LMS was performed with assistance of Optiflow(HFNO).

Experimental: Non-intubated LMS with dexmedetomidine

The patient received a non-intubated LMS optiflow (HFNO) device and was administered dexmedetomidine.

Procedure: Non-intubated Laryngomicrosurgery
Non-intubated LMS was performed with assistance of Optiflow(HFNO).

Outcome Measures

Primary Outcome Measures

  1. PaCO2 after Laryngomicrosurgery [ABG was measured immediately after the end of LMS]

    arterial blood gas(ABG) was measured immediately after the end of LMS

Secondary Outcome Measures

  1. PaO2 after Laryngomicrosurgery [ABG was measured immediately after the end of LMS]

    ABG was measured immediately after the end of LMS

  2. Hemodynamics data during LMS [during the LMS procedure]

    Hemodynamic data were measured every 5 minutes

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects are between 20-80 years old.

  • Patients undergoing laryngoscope microsurgery.

  • Anesthesiologists rated ASA as between I and III.

Exclusion Criteria:
  • Having drug dependence and drinking habits.

  • Abnormal heart, liver and kidney function.

  • Allergic reactions to narcotic drugs.

  • Emergency surgery.

  • pregnancy.

  • Refuse to participate.

  • BMI ≥ 40 kg/m2.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaohsiung Veterans General Hospital Kaohsiung Taiwan 81362

Sponsors and Collaborators

  • Kaohsiung Veterans General Hospital.

Investigators

  • Study Director: Yuan Yi Chia, Director, Kaohsiung Veterans General Hospital.
  • Study Director: Yu Ting Kuo, physician, Kaohsiung Veterans General Hospital.
  • Study Director: Ting Shou Chang, physician, Kaohsiung Veterans General Hospital.
  • Study Chair: Chih Chi Tsai, RA, Kaohsiung Veterans General Hospital.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yuan-Yi Chia, Chief of Anesthesiology, Kaohsiung Veterans General Hospital.
ClinicalTrials.gov Identifier:
NCT05581485
Other Study ID Numbers:
  • KSVGH22-CT8-38
First Posted:
Oct 14, 2022
Last Update Posted:
Feb 2, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yuan-Yi Chia, Chief of Anesthesiology, Kaohsiung Veterans General Hospital.

Study Results

No Results Posted as of Feb 2, 2023